Results 91 to 100 of about 412,436 (221)

Nurse‐Led Patient‐Reported Outcome Assessment of Symptom Burden and Quality of Life in Myeloproliferative Neoplasms: An Observational Study

open access: yesNursing Open, Volume 13, Issue 9, September 2026.
ABSTRACT Aim To investigate the symptom burden associated with MPNs and its impact on patients' psychophysical well‐being and quality of life through a structured PROM‐based nurse‐led visit. Design Observational study. Methods We included MPN patients followed at the haematology outpatient clinic of a large university‐affiliated hospital in Italy. Data
Daniela Berardinelli   +10 more
wiley   +1 more source

Serum transferrin receptor in polycythemia

open access: yesHaematologica, 1998
We measured serum transferrin receptor (sTfR) levels in 22 patients with polycythemia vera and in 26 cases of secondary polycythemia. In our study, raised sTfR levels in both polycythemia groups were related to iron deficiency.
R Manteiga   +3 more
doaj  

Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera

open access: yesHaematologica, 2009
To further characterize JAK2 exon 12 mutations, we performed molecular screening in 409 patients with polycythemia vera or unclear erythrocytosis with unmutated JAK2V617. The frequency of JAK2exon12 mutations was 10/63 (15.9%) in PV but only 5/346 (1.4%)
Susanne Schnittger   +14 more
doaj   +1 more source

Macrophages support pathological erythropoiesis in Polycythemia Vera and Beta-Thalassemia [PDF]

open access: yes, 2014
Regulation of erythropoiesis is achieved by integration of distinct signals. Among these, macrophages are emerging as erythropoietin-complementary regulators of erythroid development, particularly under stress conditions. We investigated the contribution
Abdel-Wahab, Omar   +15 more
core   +1 more source

Impending anterior ischemic optic neuropathy with elements of retinal vein occlusion in a patient on interferon for polycythemia vera

open access: yesClinical Ophthalmology, 2012
Kelly S Rue, Louis K Hirsch, Alfredo A SadunDepartment of Neuro-Ophthalmology, Doheny Eye Institute and Keck School of Medicine, University of Southern California, Los Angeles, CA, USAAbstract: We describe the course and likely pathophysiology of ...
Rue KS, Hirsch LK, Sadun AA
doaj  

Superior Vena Cava Syndrome in a Patient with Polycytemia Vera: Diagnosis and Treatment

open access: yesCardiology Research and Practice, 2010
Polycythemia vera is a myeloproliferative disorder characterized by thrombotic complications both in the arterial and venous systems. We report the case of a 55-year-old patient affected by polycythemia vera, presenting with acute superior vena cava ...
Salvatore Lentini   +3 more
doaj   +1 more source

Subarachnoid hemorrhage and diplopia as initial presentation of polycythemia vera [PDF]

open access: yes, 2005
Hamann, Gerhard F.   +4 more
core   +1 more source

Prevention of thrombosis in polycythemia vera and essential thrombocythemia

open access: yes, 2008
Identifying the most safe and effective strategy for reducing the vascular risk of subjects with polycythemia vera and essential thrombocythemia has always been challenging.
Landolfi, Raffaele, Di Gennaro, Leonardo
core   +1 more source

A rare case of extramedullary hematopoiesis: when the pericardium produces blood cells

open access: yesThe Egyptian Heart Journal
Background Cardiac tamponade is an extreme cardiological emergency, fatal in the absence of rapid intervention. This case report highlights a noteworthy and rare correlation between post-polycythemia vera myelofibrosis and extramedullary hematopoiesis ...
SALAH-EDDINE HAYAR   +9 more
doaj   +1 more source

Allele burden expansion in JAK2V617F and CALR‐mutated myeloproliferative neoplasms predicts disease progression and is associated with anagrelide treatment

open access: yes
HemaSphere, Volume 10, Issue 9, September 2026.
Zi Yun Ng   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy